Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Michael Tuttle

Showing results (61-70 of 320) with videos related to

Pageof 32
Sort By:
Thyroid : Official Journal of the American Thyroid Association|March 8, 2023
Large (>4 cm) Intrathyroidal Encapsulated Well-Differentiated Follicular Cell-Derived Carcinoma Without Vascular Invasion May Have Negligible Risk of Recurrence Even When Treated with Lobectomy AloneRonald Ghossein, Ian Ganly, R Michael Tuttle, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 11, 2020
Multifocality in papillary thyroid carcinoma-An unresolved controversyAshok R Shaha, Vincent Vander Poorten, R Michael Tuttle
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 12, 2018
Implementing Key Changes in the American Thyroid Association 2015 Thyroid Nodules/Differentiated Thyroid Cancer Guidelines Across Practice TypesChristine L Twining, Mark A Lupo, R Michael Tuttle
Clinical Endocrinology|April 28, 2011
Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancerF Vaisman, A Shaha, S Fish, et al.
Thyroid : Official Journal of the American Thyroid Association|April 16, 2016
Challenges of Active Surveillance Protocols for Low-Risk Papillary Thyroid Microcarcinoma in the United StatesGrace C Haser, R Michael Tuttle, Mark L Urken
The Lancet. Diabetes & Endocrinology|August 24, 2016
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?Sophie Leboulleux, R Michael Tuttle, Furio Pacini, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2012
Skeletal-related events due to bone metastases from differentiated thyroid cancerAzeez Farooki, Vivien Leung, Hernan Tala, et al.
CA: a Cancer Journal for Clinicians|November 2, 2017
Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manualNancy D Perrier, James D Brierley, R Michael Tuttle
Journal of Surgical Oncology|October 24, 2020
Completion thyroidectomy-Have we made appropriate decisions?Ashok R Shaha, Kepal N Patel, R Michael Tuttle
JAMA Otolaryngology-- Head & Neck Surgery|April 15, 2016
Changing Trends in the Incidence of Thyroid Cancer in the United StatesLuc G T Morris, R Michael Tuttle, Louise Davies
Pageof 32

Showing results (61-70 of 320) with videos related to

Sort By:
Pageof 32
Thyroid : Official Journal of the American Thyroid Association|March 8, 2023
Large (>4 cm) Intrathyroidal Encapsulated Well-Differentiated Follicular Cell-Derived Carcinoma Without Vascular Invasion May Have Negligible Risk of Recurrence Even When Treated with Lobectomy AloneRonald Ghossein, Ian Ganly, R Michael Tuttle, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 11, 2020
Multifocality in papillary thyroid carcinoma-An unresolved controversyAshok R Shaha, Vincent Vander Poorten, R Michael Tuttle
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 12, 2018
Implementing Key Changes in the American Thyroid Association 2015 Thyroid Nodules/Differentiated Thyroid Cancer Guidelines Across Practice TypesChristine L Twining, Mark A Lupo, R Michael Tuttle
Clinical Endocrinology|April 28, 2011
Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancerF Vaisman, A Shaha, S Fish, et al.
Thyroid : Official Journal of the American Thyroid Association|April 16, 2016
Challenges of Active Surveillance Protocols for Low-Risk Papillary Thyroid Microcarcinoma in the United StatesGrace C Haser, R Michael Tuttle, Mark L Urken
The Lancet. Diabetes & Endocrinology|August 24, 2016
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?Sophie Leboulleux, R Michael Tuttle, Furio Pacini, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2012
Skeletal-related events due to bone metastases from differentiated thyroid cancerAzeez Farooki, Vivien Leung, Hernan Tala, et al.
CA: a Cancer Journal for Clinicians|November 2, 2017
Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manualNancy D Perrier, James D Brierley, R Michael Tuttle
Journal of Surgical Oncology|October 24, 2020
Completion thyroidectomy-Have we made appropriate decisions?Ashok R Shaha, Kepal N Patel, R Michael Tuttle
JAMA Otolaryngology-- Head & Neck Surgery|April 15, 2016
Changing Trends in the Incidence of Thyroid Cancer in the United StatesLuc G T Morris, R Michael Tuttle, Louise Davies
Pageof 32